Sinovac seeks approval to use COVID-19 vaccine on those aged 3 to 17 | Inquirer News

Sinovac seeks approval to use COVID-19 vaccine on those aged 3 to 17

By: - Reporter / @DYGalvezINQ
/ 12:53 AM July 07, 2021

MANILA, Philippines — China-based drugmaker Sinovac Biotech has sought authorization to use its COVID-19 vaccine CoronaVac on those aged 3 to 17, Food and Drug Administration (FDA) Director-General Eric Domingo said Tuesday during the briefing with President Rodrigo Duterte early Wednesday.

Domingo said the Chinese pharmaceutical firm has applied for an amendment of its emergency use authorization (EUA) to include those aged 3 to 17.

Article continues after this advertisement

At present, Sinovac’s EUA  recommends its use on those aged 18 and above.

FEATURED STORIES

The country’s vaccine experts will study the data and get more information from the drug firm.

“This is another potential vaccine that can be used for the pediatric age group.  We are studying this, maybe within the month, to see if we will be able to allow the use of Sinovac in children,” Domingo said.

Article continues after this advertisement

In June, China approved the emergency use of Sinovac’s vaccine on those aged 3 to 17.

So far, only the US-made Pfizer COVID-19 vaccine can be used on children, particularly those aged 12 to 15.

[atm]
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: FDA, Sinovac

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.